Array BioPharma narrows quarterly loss

BOULDER – Drug research company Array BioPharma Inc. reported increased revenue and a narrower loss for the quarter ended Sept. 30.

Boulder-based Array (Nasdaq: ARRY) generated $22.1 million in revenue for its first quarter of fiscal 2012 compared with revenue of $18.5 million for the same period in fiscal 2011, the company said in a statement.

Net loss for the quarter was $3.58 million, or 6 cents a share, compared with a loss of $10.63 million, or 20 cents a share, for the same quarter a year earlier, the company reported.

Included in the revenue figure was $2.5 million the company earned for…